Here's the live share price of Procter & Gamble Health along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Procter & Gamble Health has gained 3.61% CAGR. Over the past year, the corresponding return has been 20.43%.
Procter & Gamble Health’s current P/E of 34.63x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Procter & Gamble Health | -3.04 | 0.95 | 6.15 | 21.87 | 21.62 | 13.37 | 3.61 |
Sun Pharmaceutical Industries | 0.46 | -1.83 | -4.93 | -6.07 | -13.98 | 21.68 | 26.44 |
Divi's Laboratories | 0.68 | -2.03 | -9.69 | 6.55 | 10.26 | 18.00 | 13.79 |
Cipla | -0.18 | -0.98 | 1.45 | 3.75 | -6.67 | 13.52 | 16.50 |
Torrent Pharmaceuticals | -3.05 | -3.34 | 7.71 | 15.39 | 2.27 | 32.67 | 20.35 |
Dr. Reddy's Laboratories | 0.65 | 3.01 | -3.33 | 13.16 | -2.09 | 15.26 | 8.32 |
Mankind Pharma | -0.41 | 4.42 | 8.91 | 18.73 | 4.99 | 21.89 | 12.61 |
Zydus Lifesciences | 0 | 5.08 | 6.44 | 16.05 | -7.08 | 40.26 | 22.98 |
Lupin | 4.49 | 3.93 | 1.81 | 2.80 | -9.12 | 44.83 | 16.16 |
Abbott India | 1.08 | -5.07 | -2.16 | 2.66 | 6.29 | 19.99 | 13.39 |
Alkem Laboratories | 3.00 | 2.66 | 12.83 | 14.01 | -13.62 | 19.58 | 13.54 |
Aurobindo Pharma | 5.23 | 0.79 | -3.96 | -1.28 | -29.67 | 25.72 | 6.67 |
Glenmark Pharmaceuticals | -0.85 | 6.28 | 24.71 | 46.64 | 20.47 | 74.71 | 34.18 |
Laurus Labs | -0.70 | 3.54 | 31.78 | 54.09 | 77.57 | 17.47 | 27.44 |
Biocon | -1.70 | -1.58 | 0.32 | 7.35 | -8.27 | 5.74 | -3.58 |
Anthem Biosciences | 1.94 | 4.25 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
GlaxoSmithKline Pharmaceuticals | -2.35 | -1.35 | -18.25 | 2.21 | -2.76 | 24.76 | 9.75 |
Cohance Lifesciences | -3.42 | 9.49 | -0.98 | -13.33 | -15.99 | 26.86 | 22.11 |
Ipca Laboratories | -0.43 | -5.15 | -3.58 | -0.16 | -9.98 | 13.54 | 4.09 |
Gland Pharma | 4.52 | 1.75 | 13.40 | 29.15 | 7.54 | -6.26 | 1.96 |
Over the last one year, Procter & Gamble Health has gained 21.62% compared to peers like Sun Pharmaceutical Industries (-13.98%), Divi's Laboratories (10.26%), Cipla (-6.67%). From a 5 year perspective, Procter & Gamble Health has underperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Day | SMA | EMA |
---|---|---|
5 | 6,426.42 | 6,344.35 |
10 | 6,391.24 | 6,363.19 |
20 | 6,355.24 | 6,331.92 |
50 | 6,111.66 | 6,157.45 |
100 | 5,806.83 | 5,925.06 |
200 | 5,555.55 | 5,672.03 |
In the latest quarter, Procter & Gamble Health remained same as its previous close in promoter holding, while DII stake decreased to 14.15%, FII holding rose to 6.99%, and public shareholding moved down to 27.03% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Nippon India Small Cap Fund | 6,92,659 | 0.68 | 441.22 |
ICICI Prudential Smallcap Fund | 3,67,538 | 2.77 | 234.12 |
UTI MNC Fund | 2,40,895 | 5.36 | 153.45 |
DSP Healthcare Fund | 1,59,288 | 3.27 | 101.47 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 78,012 | 0.81 | 49.69 |
UTI Healthcare Fund | 70,039 | 3.99 | 44.61 |
Aditya Birla Sun Life MNC Fund - Div | 69,716 | 1.2 | 44.41 |
Aditya Birla Sun Life MNC Fund - Gr | 69,716 | 1.2 | 44.41 |
ICICI Prudential Bharat Consumption Fund | 23,552 | 0.46 | 15 |
Aditya Birla Sun Life Pharma & Healthcare Fund | 19,000 | 1.43 | 12.1 |
Date Time | Announcement |
---|---|
Sep 08, 2025, 11:55 PM IST | P&G Health - Announcement under Regulation 30 (LODR)-Change in Management |
Sep 02, 2025, 12:10 AM IST | P&G Health - Change In Senior Management Personnel Of The Company |
Aug 30, 2025, 1:06 AM IST | P&G Health - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Aug 30, 2025, 12:54 AM IST | P&G Health - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 26, 2025, 5:35 AM IST | P&G Health - Intimation Regarding IEPF''s 100 Days Campaign - 'Saksham Niveshak |
Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 934.17 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Procter & Gamble Health is ₹6,271.10 as on Sep 15, 2025.
The Procter & Gamble Health is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Procter & Gamble Health is ₹10,409.64 Cr as on Sep 15, 2025.
Today’s highest and lowest price of Procter & Gamble Health are ₹6,324.05 and ₹6,203.55.
The 52-week high/low is the highest and lowest price at which Procter & Gamble Health stock has traded in the past 52-week or nearly a year. The 52-week high of Procter & Gamble Health is ₹6,700.00 and 52-week low of Procter & Gamble Health is ₹4,912.30 as on Sep 15, 2025.
The Procter & Gamble Health has shown returns of 0.24% over the past day, 1.46% for the past month, 7.4% over 3 months, 20.43% over 1 year, 13.37% across 3 years, and 3.61% over 5 years.
P/E ratio of and PB ratio of Procter & Gamble Health are 34.63 and 16.77 on Sep 15, 2025. While the company gives a dividend yield of 1.99 per annum.